Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study.

Li Yang; Torsten Christensen; Fengyu Sun; Jinghua Chang

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study.

【24h】

Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study.

机译：从胰岛素狼氨酸到胰岛素DEDIMIR中的2型糖尿病切换患者的成本效益：基于预测研究的卫生经济模式。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Conversion to IDet from an IGla regimen improved life expectancy and was a cost-saving treatment approach in a Chinese setting.

机译：从IGLA方案转换为IDET改善了预期寿命，并在中国环境中是一种节省成本的处理方式。

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research》 |2012年第1期|共4页
作者
Li Yang; Torsten Christensen; Fengyu Sun; Jinghua Chang;
展开▼
作者单位

Department of Health Policy and Management School of Public Health Peking University Beijing;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study. [J] . Li Yang, Torsten Christensen, Fengyu Sun, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2012,第Suppla1期

机译：在中国地区将2型糖尿病患者从甘精胰岛素换为地特胰岛素的成本效益：基于预测研究的健康经济模型。
2. Cost-Effectiveness of Insulin Glargine and Insulin Detemir in the Basal Regimen for Na?ve Insulin Patients with Type 2 Diabetes Mellitus (T2DM) in Malaysia [J] . Asrul Akmal Shafie, Chin Hui Ng ClinicoEconomics and Outcomes Research . 2020,第4期

机译：在马来西亚患有2型糖尿病（T2DM）的Na-Ve胰岛素患者基础胰岛素患者中胰岛素狼蛛和胰岛素DECIMIR的成本效果
3. A 1‐year, prospective, observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) [J] . Shimoda Seiya, Sato Miki, Sekigami Taiji, Journal of diabetes investigation. . 2016,第5期

机译：一项为期1年的前瞻性观察性研究，对日本的1型和2型糖尿病门诊患者在基础推注胰岛素治疗中从甘精胰岛素或地特米尔胰岛素转为地格列酮胰岛素（熊本Insulin Degludec观察研究）
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. A 1‐year prospective observational study of Japanese outpatients with type 1 and type 2 diabetes switching from insulin glargine or detemir to insulin degludec in basal–bolus insulin therapy (Kumamoto Insulin Degludec Observational study) [O] . Seiya Shimoda, Miki Sato, Taiji Sekigami, 2016

机译：一项为期1年的前瞻性观察性研究针对日本的1型和2型糖尿病患者在基础推注胰岛素治疗中从甘精胰岛素或地特米尔胰岛素转为地格列酮胰岛素（熊本Insulin Degludec观察性研究）
7. Cost-Effectiveness of Switching Patients with Type 2 Diabetes from Insulin Glargine to Insulin Detemir in Chinese Setting: A Health Economic Model Based on the PREDICTIVE Study [O] . Yang Li, Christensen Torsten, Sun Fengyu, 2012

机译：在中国背景下将2型糖尿病患者从甘精胰岛素转换为Detemir的成本-效果：基于预测研究的健康经济模型

Cost-effectiveness of switching patients with type 2 diabetes from insulin glargine to insulin detemir in Chinese setting: a health economic model based on the PREDICTIVE study.

摘要

著录项

相似文献

相关主题

期刊订阅